Larry Altstiel

Direttore Tecnico/Scientifico/R&S presso PROMIS NEUROSCIENCES, INC.

Patrimonio netto: - $ in data 30/04/2024

74 anni

Health Technology

Consumer Services

Posizioni attive di Larry Altstiel

Società	Posizione	Inizio	Fine
PROMIS NEUROSCIENCES, INC.	Direttore Tecnico/Scientifico/R&S	19/04/2022	-
Pinteon Therapeutics, Inc. Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA.	Direttore Tecnico/Scientifico/R&S	-	-

Società	Posizione	Inizio	Fine
VTV THERAPEUTICS INC.	Direttore Tecnico/Scientifico/R&S	01/12/2015	30/04/2018
NEUROTROPE, INC.	Direttore/Membro del Consiglio	12/09/2014	11/02/2016
Provectra Therapeutics, Inc. Provectra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provectra Therapeutics, Inc. manufactures pharmaceutical products. The private company is based in Chapel Hill, NC. The company was founded by Larry Douglas Altstiel.	Amministratore Delegato	01/02/2013	01/12/2015
	Fondatore	01/02/2013	01/12/2015
PFIZER, INC.	Corporate Officer/Principal	01/01/2007	01/01/2013
Schering Plough, Inc.	Corporate Officer/Principal	-	-
Eisai Medical Research, Inc.	Corporate Officer/Principal	-	-
UCB BioSciences, Inc.	Corporate Officer/Principal	-	-

University of Illinois	Undergraduate Degree
The Rockefeller University	Doctorate Degree
The University of Miami Leonard M. Miller School of Medicine	Doctorate Degree

Distribuzione geografica

Stati Uniti	12
Canada	2

Posizioni

Corporate Officer/Principal	4
Chief Tech/Sci/R&D Officer	3
Doctorate Degree	2

Settori

Health Technology	7
Consumer Services	4

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	6
Neurotrope, Inc. Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY.	Health Technology
Pinteon Therapeutics, Inc. Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA.	Health Technology
Eisai Medical Research, Inc.
UCB BioSciences, Inc.
Schering Plough, Inc.
Provectra Therapeutics, Inc. Provectra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provectra Therapeutics, Inc. manufactures pharmaceutical products. The private company is based in Chapel Hill, NC. The company was founded by Larry Douglas Altstiel.	Health Technology